Effect of radiotherapy and chemotherapy on pulmonary function after treatment for breast cancer and lymphoma: A follow-up study

Journal of Clinical Oncology

Volumn 17, Issue 10, 1999, Pages 3091-3100

  Theuws, Jacqueline C M ^a   Muller, Sara H ^a   Seppenwoolde, Yvette ^a   Kwa, Stefan L S ^a   Boersma, Liesbeth J ^a   Hart, Guus A M ^a   Baas, Paul ^a   Lebesque, Joos V ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BLEOMYCIN; CARBON MONOXIDE; CARBOPLATIN; CHLORMETHINE DERIVATIVE; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; METHOTREXATE; PREDNISONE; PROCARBAZINE; THIOTEPA; VINBLASTINE; VINCRISTINE;

ADOLESCENT; ADULT; AGED; ARTICLE; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CONTROLLED STUDY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION; LUNG VOLUME; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIATION DOSE DISTRIBUTION; TREATMENT OUTCOME; VITAL CAPACITY;

EID: 0032887955     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1999.17.10.3091     Document Type: Article

References (48)

1. Emami B, Lyman J, Brown A, et al: Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 21:109-122, 1991
2. Boersma LJ, Damen EM, de Boer RW, et al: Dose-effect relations for local functional and structural changes of the lung after irradiation for malignant lymphoma. Radiother Oncol 32:201-209, 1994
3. Boersma LJ, Damen EM, de Boer RW, et al: Estimation of overall pulmonary function after irradiation using dose-effect relations for local functional injury. Radiother Oncol 36:15-23, 1995
4. Theuws JCM, Kwa SLS, Wagenaar A, et al: Dose-effect relations for early local pulmonary injury after irradiation for malignant lymphoma and breast cancer. Radiother Oncol 48:33-43, 1998
5. Theuws JCM, Kwa SLS, Wagenaar AC, et al: Prediction of overall pulmonary function loss in relation to the 3-D dose distribution, for patients with breast cancer and malignant lymphoma. Radiother Oncol 49:233-243, 1998
6. Bjermer L, Franzen L, Littbrand B, et al: Effects of smoking and irradiated volume on inflammatory response in the lung of irradiated breast cancer patients evaluated with bronchoalveolar lavage. Cancer Res 50:2027-2030, 1990
7. Johansson S, Bjermer L, Franzen L, et al: Influence of smoking on the development of radiation induced pneumonitis of breast cancer and oesophagus cancer patients. Radiother Oncol 40:S43, 1996 (suppl, abstr)
8. Marks LB, Munley MT, Bentel GC, et al: Physical and biological predictors of changes in whole-lung function following thoracic irradiation. Int J Radiat Oncol Biol Phys 39:563-570, 1997
9. Burman C, Kutcher GJ, Emami B, et al: Fitting of normal tissue tolerance data to an analytic function. Int J Radiat Oncol Biol Phys 21:123-135, 1991
10. Jackson A, Kutcher GJ, Yorke ED: Probability of radiation-induced complications for normal tissues with parallel architecture subject to non-uniform irradiation. Med Phys 20:613-625, 1993
11. Niemierko A, Goitein M: Modeling of normal tissue response to radiation: The critical volume model. Int J Radiat Oncol Biol Phys 25:135-145, 1993
12. Yorke ED, Kutcher GJ, Jackson A, et al: Probability of radiation-induced complications in normal tissues with parallel architecture under conditions of uniform whole or partial organ irradiation. Radiother Oncol 26:226-237, 1993
13. Choi NC, Kanarek DJ, Grillo HC: Effect of postoperative radiotherapy on changes in pulmonary function in patients with stage II and IIIA lung carcinoma. Im J Radial Oncol Biol Phys 18:95-99, 1990
14. Curran WJ Jr, Moldofsky PJ, Solin LJ: Observations on the predictive value of perfusion lung scans on post-irradiation pulmonary function among 210 patients with bronchogenic carcinoma. Int J Radiat Oncol Biol Phys 24:31-36, 1992
15. Rubenstein JH, Richter MP, Moldofsky PJ, et al: Prospective prediction of post-radiation therapy lung function using quantitative lung scans and pulmonary function testing. Int J Radiat Oncol Biol Phys 15:83-87, 1988
16. Hardman PD, Tweeddale PM, Kerr GR, et al: The effect of pulmonary function of local and loco-regional irradiation for breast cancer. Radiother Oncol 30:33-42, 1994
17. Lund MB, Myhre KI, Melsom H, et al: The effect on pulmonary function of tangential field technique in radiotherapy for carcinoma of the breast. Br J Radiol 64:520-523, 1991
18. Lokich JJ, Bass H, Eberly FE, et al: The pulmonary effect of mantle irradiation in patients with Hodgkin's disease. Radiology 108:397-402, 1973
19. Smith LM, Mendenhall NP, Cicale MJ, et al: Results of a prospective study evaluating the effects of mantle irradiation on pulmonary function. Int J Radiat Oncol Biol Phys 16:79-84, 1989
20. Horning SJ, Adhikari A, Rizk N, et al: Effect of treatment for Hodgkin's disease on pulmonary function: Results of a prospective study. J Clin Oncol 12:297-305, 1994
21. Choi NC, Kanarek DJ: Toxicity of thoracic radiotherapy on pulmonary function in lung cancer. Lung Cancer 10:S219-S230, 1994 (suppl 1)
22. Gross NJ: Pulmonary effects of radiation therapy. Ann Intern Med 86:81-92, 1977 (review)
23. Quanjer PH, Andersen LH, Tammeling GJ: Clinical respiratory physiology. Bull Eur Physiopathol Respir 19:11-21, 1983
24. Boersma LJ, Damen EM, de Boer RW, et al: A new method to determine dose-effect relations for local lung-function changes using correlated SPECT and CT data. Radiother Oncol 29:110-116, 1993
25. Dubray B, Henry-Amar M, Meerwaldt JH, et al: Radiation-induced lung damage after thoracic irradiation for Hodgkin's disease: The role of fractionation. Radiother Oncol 36:211-217, 1995
26. Altman DG: Comparing groups: continuous data, in Practical Statistics for Medical Research (ed 1). London, UK, Chapman and Hall, 1991, pp 210-212
27. Botterman J, Tasson J, Schelstraete K, et al: Scintigraphic, spirometric, and roentgenologic effects of radiotherapy on normal lung tissue: Short-term observations in 14 consecutive patients with breast cancer. Chest 97:97-102, 1990
28. Lund MB, Kongerud J, Nome O, et al: Lung function impairment in long-term survivors of Hodgkin's disease. Ann Oncol 6:495-501, 1995
29. Newman G, Bell J, Goddard P, et al: Pulmonary changes in breast cancer patients treated by three different radiotherapy techniques. Clin Oncol (R Coll Radiol) 1:91-96, 1989
30. Cionini L, Pacini P, De Paola E, et al: Respiratory function tests after mantle irradiation in patients with Hodgkin's disease. Acta Radiol Oncol 23:401-409, 1984
31. Evans RF, Sagerman RH, Ringrose TL, et al: Pulmonary function following mantle-field irradiation for Hodgkin's disease. Radiology 111:729-731, 1974
32. Host H, Vale JR: Lung function after mantle field irradiation in Hodgkin's disease. Cancer 32:328-332, 1973
33. do Pico GA, Wiley AL Jr, Rao P, et al: Pulmonary reaction to upper mantle radiation therapy for Hodgkin's disease. Chest 75:688-692, 1979
34. Watchie J, Coleman CN, Raffin TA, et al: Minimal long-term cardiopulmonary dysfunction following treatment for Hodgkin's disease. Int J Radiat Oncol Biol Phys 13:517-524, 1987
35. Hassink EA, Souren TS, Boersma LJ, et al: Pulmonary morbidity 10-18 years after irradiation for Hodgkin's disease. Eur J Cancer 29A:343-347, 1993
36. Morgan GW, Freeman AP, McLean RG, et al: Late cardiac, thyroid, and pulmonary sequelae of mantle radiotherapy for Hodgkin's disease. Int J Radiat Oncol Biol Phys 11:1925-1931, 1985
37. Allavena C, Conroy T, Aletti P, et al: Late cardiopulmonary toxicity after treatment for Hodgkin's disease. Br J Cancer 65:908-912, 1992
38. Jensen BV, Carlsen NL, Groth S, et al: Late effects on pulmonary function of mantle-field irradiation, chemotherapy or combined modality therapy for Hodgkin's disease. Eur J Haematol 44:165-171, 1990
39. Collis CH: Lung damage from cytotoxic drugs. Cancer Chemother Pharmacol 4:17-27, 1980 (review)
40. Israel-Biet D, Labrune S, Huchon GJ: Drug-induced lung disease: 1990 Review. Eur Respir J 4:465-478, 1991
41. Cooper JA Jr, White DA, Matthay RA: Drug-induced pulmonary disease: Part 1 - Cytotoxic drugs. Am Rev Respir Dis 133:321-340, 1986 (review)
42. Van R, Peters LJ, Travis EL: Cyclophosphamide 24 hours before or after total body irradiation: Effects on lung and bone marrow. Radiother Oncol 21:149-156, 1991 (review)
43. von der Maase H, Overgaard J, Vaeth M: Effect of cancer chemotherapeutic drugs on radiation-induced lung damage in mice. Radiother Oncol 5:245-257, 1986
44. Kimsey FC, Mendenhall NP, Ewald LM, et al: Is radiation treatment volume a predictor for acute or late effect on pulmonary function? A prospective study of patients treated with breast-conserving surgery and postoperative irradiation. Cancer 73:2549-2555, 1994
45. Knudson RJ, Kaltenborn WT, Burrows B: The effects of cigarette smoking and smoking cessation on the carbon monoxide diffusing capacity of the lung in asymptomatic subjects. Am Rev Respir Dis 140:645-651, 1989
46. Sansores RH, Pare PD, Abboud RT: Acute effect of cigarette smoking on the carbon monoxide diffusing capacity of the lung. Am Rev Respir Dis 146:951-958, 1992
47. Kwa SL, Lebesque JV, Theuws JC, et al: Radiation pneumonitis as a function of mean lung dose: An analysis of pooled data of 540 patients. Int J Radiat Oncol Biol Phys 42:1-9, 1998
48. Anscher MS, Kong FM, Marks LB, et al: Changes in plasma transforming growth factor beta during radiotherapy and the risk of symptomatic radiation-induced pneumonitis. Int J Radiat Oncol Biol Phys 37:253-258, 1997